Hillsdale Investment Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,600
Closed -$468K 649
2025
Q1
$468K Buy
44,600
+1,300
+3% +$14.7K 0.02% 370
2024
Q4
$524K Buy
43,300
+900
+2% +$11.8K 0.03% 352
2024
Q3
$623K Buy
42,400
+6,300
+17% +$87.8K 0.05% 336
2024
Q2
$521K Buy
+36,100
New +$577K 0.04% 328

Other funds holding ELAN

Hillsdale Investment Management's ELAN Position: Q2 2025 in Review

Hillsdale Investment Management sold out of Elanco Animal Health (ELAN) in Q2 2025, closing a stake of 44,600 shares — an estimated $468K sold.

Hillsdale Investment Management first reported a position in ELAN in Q2 2024 and held it in 4 quarters. The position peaked at $623K in Q3 2024. 368 funds tracked by Wall St. Rank hold ELAN as of Q2 2025.

  • Hillsdale Investment Management reported no remaining Elanco Animal Health position as of Q2 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 44,600 Elanco Animal Health shares in Q2 2025, an estimated $468K.
  • Hillsdale Investment Management first reported a position in Elanco Animal Health in Q2 2024 and held it in 4 quarters.
  • Hillsdale Investment Management's Elanco Animal Health position peaked at $623K in Q3 2024.
  • 368 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2025.

Based on Hillsdale Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.